Jim Cramer says this one word is now the kiss of death on a conference call.
Jim Cramer goes through his lightning round of callers, and weighs in on the state of oil ahead of the rig count.
Express Scripts said despite the double-digit increase, costs for employers rose just 2.5 percent across all prescription drugs.
The leader of the biggest U.S. benefits manager believes an Obamacare replacement can be crafted to save money for the nation and for Americans.
Tim Wentworth, Express Scripts CEO, says the company has invested heavily in digital tools to help members access the lowest price drugs.
Tim Wentworth, Express Scripts CEO, talks to CNBC's Meg Tirrell, about ways to drive down the low-term cost of drugs.
Citron Research says Express Scripts is the "Gotti of Pharma."
CNBC's Jim Cramer gives insight to investors about whether they should jump into the market or wait now that the Dow has passed the 20,000 milestone.
Mylan CEO Heather Bresch speaks to CNBC's Meg Tirrell about the future of EpiPen pricing under President-elect Donald Trump as he pushes to bring drug prices down.
Mylan CEO Heather Bresch speaks to CNBC's Meg Tirrell about the future of EpiPen pricing.
CNBC's Meg Tirrell speaks with Express Scripts President & CEO Tim Wentworth on pharmacy benefit managers and drug pricing pressure.
Pharmaceutical industry’s middlemen face a greater scrutiny next year, according to Breakingviews.
This is a stock picker's market, says Bob Doll, Nuveen Asset Management, providing his top stock plays. I love the airlines, says Doll.
CNBC's Meg Tirrell reports on the launch of Mylan's "authorized generic" version of their EpiPen.
Some of the names on the move ahead of the open.
John Fichthorn of Dialectic Capital discusses his latest short positions, including AutoNation, Carmax and more.
Earlier Thursday, Left's Citron Research called Express Scripts the "Philidor of the pharma industry."
Citron Research's Thursday afternoon tweet sent shares of Express Scripts tanking, and someone appeared ideally positioned for the move.
Short-seller Andrew Left, Citron Research, discusses his tweet directing Donald Trump's attention towards Express Scripts, and his other shorts in the pharmaceutical space.
Short-seller Andrew Left, Citron Research, explains why Express Scripts is the "Philidor of the pharma industry," referring to Philidor Rx Services' alleged misconduct with Valeant Pharmaceuticals.